See the Full Picture.
Published loading...Updated

Real-world Radicava use in ALS tied to unexpected side effects

Summary by ALS News Today
The real-world use of Radicava (edaravone), an infusion treatment approved for amyotrophic lateral sclerosis (ALS), may cause serious side effects — such as liver problems, blood clots, pain, brain bleeding, and infection — not previously listed in its label, according to data from the U.S. drug regulatory agency’s adverse event reporting system. These findings, culled from U.S. Food and Drug Administration (FDA) reporting information, provide u…
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

ALS News Today broke the news in on Wednesday, May 7, 2025.
Sources are mostly out of (0)